Dongmei Jia - Search Results

Year	Number of Results
2003	3
2004	1
2005	2
2006	2
2007	2
2008	1
2009	1
2010	1
2011	2
2012	1
2013	2
2014	1
2015	1
2016	2
2017	1
2019	2
2020	6
2021	17
2022	9
2023	5
2024	8
2025	10
2026	3

1

B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune Disease.

Zhang C, Zhang TX, Liu Y, Jia D, Zeng P, Du C, Yuan M, Liu Q, Wang Y, Shi FD. Zhang C, et al. Among authors: jia d. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 31;8(6):e1070. doi: 10.1212/NXI.0000000000001070. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34465614 Free PMC article.

2

Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder.

Zhang TX, Yang X, Gao X, Du X, Lian X, Shao N, Liu Y, Huang Z, Jia D, Lau AYL, Li Z, Kokaia Z, Shi FD, Zhang C. Zhang TX, et al. Among authors: jia d. Adv Sci (Weinh). 2025 Oct;12(38):e00942. doi: 10.1002/advs.202500942. Epub 2025 Jul 21. Adv Sci (Weinh). 2025. PMID: 40686188 Free PMC article.

3

tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.

Shi K, Zou M, Jia DM, Shi S, Yang X, Liu Q, Dong JF, Sheth KN, Wang X, Shi FD. Shi K, et al. Circ Res. 2021 Jan 8;128(1):62-75. doi: 10.1161/CIRCRESAHA.120.317596. Epub 2020 Oct 19. Circ Res. 2021. PMID: 33070717 Free article.

4

Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.

Zhang C, Zhang M, Qiu W, Ma H, Zhang X, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett JL, Shi FD; TANGO Study Investigators. Zhang C, et al. Among authors: jia d. Lancet Neurol. 2020 May;19(5):391-401. doi: 10.1016/S1474-4422(20)30070-3. Lancet Neurol. 2020. PMID: 32333897 Free PMC article. Clinical Trial.

5

Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder.

Liu Y, Huang Z, Zhang TX, Han B, Yang G, Jia D, Yang L, Liu Q, Lau AYL, Paul F, Verkhratsky A, Shi FD, Zhang C. Liu Y, et al. Among authors: jia d. J Neuroinflammation. 2023 Dec 21;20(1):309. doi: 10.1186/s12974-023-02997-2. J Neuroinflammation. 2023. PMID: 38129902 Free PMC article.

6

Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness-implementation trial.

Moll van Charante EP, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes L, Birck C, Brooks R, Coley N, Eggink E, Georges J, Hafdi M, van Gool WA, Handels R, Hou H, Lyu J, Niu Y, Song L, Wang W, Wang Y, Wimo A, Yu Y, Zhang J, Zhang W, Brayne C, Wang W, Richard E; PRODEMOS study group. Moll van Charante EP, et al. Lancet Healthy Longev. 2024 Jun;5(6):e431-e442. doi: 10.1016/S2666-7568(24)00068-0. Epub 2024 May 16. Lancet Healthy Longev. 2024. PMID: 38763155 Free article. Clinical Trial.

7

Multiple sclerosis in China: the current state of diagnosis and management.

Jia D, Shi FD, Jiang W. Jia D, et al. Curr Opin Neurol. 2025 Jun 1;38(3):236-242. doi: 10.1097/WCO.0000000000001359. Epub 2025 Mar 19. Curr Opin Neurol. 2025. PMID: 40104913 Review.

8

Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder.

Wang C, Liu J, Gao X, Shen Y, Pan J, Yang S, Fan M, Jia D, Zhang C. Wang C, et al. Among authors: jia d. Mult Scler Relat Disord. 2025 Mar;95:106314. doi: 10.1016/j.msard.2025.106314. Epub 2025 Feb 4. Mult Scler Relat Disord. 2025. PMID: 39923413

9

A real-world comparative study on the efficacy and safety of tocilizumab and rituximab in patients with neuromyelitis optica spectrum disease and myelin oligodendrocyte glycoprotein antibody-associated disease.

Shi Y, Li Y, Xu X, Liu J, An X, Zhang M, Shen Y, Pan J, Jia D, Zhang C. Shi Y, et al. Among authors: jia d. Mult Scler Relat Disord. 2026 Jan;105:106871. doi: 10.1016/j.msard.2025.106871. Epub 2025 Nov 23. Mult Scler Relat Disord. 2026. PMID: 41317519

10

The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review.

Jia D, Zhang Y, Yang C. Jia D, et al. Neurol Sci. 2022 Aug;43(8):4695-4700. doi: 10.1007/s10072-022-06126-4. Epub 2022 May 18. Neurol Sci. 2022. PMID: 35583839 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year